March newsletter

Fisher BioServices to co-locate CryoHub with manufacturing centre

Last week Fisher BioServices announced that they would be co-locating their CryoHub solution with the Cell and Gene Therapy Catapult manufacturing centre in Stevenage. Discussing the announcement at the Alliance for Regenerative Medicine Advanced Therapies Summit in Barcelona, CEO Keith Thompson said that he was delighted with the news and that the collaboration reflects our mission to build the UK’s position as a world leader in the development and commercialisation of cell and gene therapies.